China Medicine Stock EBITDA
| CHME Stock | USD 0.0001 0.00 0.00% |
China Medicine fundamentals help investors to digest information that contributes to China Medicine's financial success or failures. It also enables traders to predict the movement of China Pink Sheet. The fundamental analysis module provides a way to measure China Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to China Medicine pink sheet.
China |
China Medicine Company EBITDA Analysis
China Medicine's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current China Medicine EBITDA | 13.41 M |
Most of China Medicine's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, China Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, China Medicine reported earnings before interest,tax, depreciation and amortization of 13.41 M. This is 98.47% lower than that of the Pharmaceuticals sector and 99.15% lower than that of the Health Care industry. The ebitda for all United States stocks is 99.66% higher than that of the company.
China EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China Medicine's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of China Medicine could also be used in its relative valuation, which is a method of valuing China Medicine by comparing valuation metrics of similar companies.China Medicine is currently under evaluation in ebitda category among related companies.
China Fundamentals
| Return On Equity | 0.0663 | |||
| Return On Asset | 0.0782 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 2 M | |||
| Shares Outstanding | 23.71 M | |||
| Price To Earning | (6.67) X | |||
| Price To Book | 0.07 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 64.75 M | |||
| Gross Profit | 18.98 M | |||
| EBITDA | 13.41 M | |||
| Net Income | 1.72 M | |||
| Cash And Equivalents | 7.85 M | |||
| Cash Per Share | 0.20 X | |||
| Total Debt | 4.05 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 11.15 X | |||
| Book Value Per Share | 1.97 X | |||
| Cash Flow From Operations | 16.96 M | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 281 | |||
| Beta | 36.82 | |||
| Market Capitalization | 284.54 K | |||
| Total Asset | 66.84 M | |||
| Retained Earnings | 24.76 M | |||
| Working Capital | 85.75 M | |||
| Current Asset | 94.2 M | |||
| Current Liabilities | 8.45 M | |||
| Z Score | 1.2 | |||
| Net Asset | 66.84 M |
About China Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with China Medicine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if China Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Medicine will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to China Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace China Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back China Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling China Medicine to buy it.
The correlation of China Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as China Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if China Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for China Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Medicine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for China Pink Sheet analysis
When running China Medicine's price analysis, check to measure China Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Medicine is operating at the current time. Most of China Medicine's value examination focuses on studying past and present price action to predict the probability of China Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Medicine's price. Additionally, you may evaluate how the addition of China Medicine to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |